Fallout from the government shutdown, Chevron expands electricity business, Cisco beats expectations, and more news to start ...
Sagimet Biosciences Inc. Phase 1 clinical trial to evaluate the PK of a combination of denifanstat and resmetirom ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback